Medical Science Liaison - Germany

About my Tomorrows

my Tomorrows is a global health tech company dedicated to breaking down barriers for patients seeking treatment options.

We strive to enable earlier and better treatment access by bridging the gap between those searching for possible options, and the companies who develop them. We work closely with patients, healthcare professionals, trial sites, patient advocacy groups, and Bio Pharma – connecting key stakeholders in the drug development ecosystem.

We’ve developed a cutting‑edge AI‑powered technology platform that simplifies and streamlines access to drugs in development. To support our users and clients, we have a range of industry‑expert specialized teams ready to help. Our services include clinical trial patient recruitment, Expanded Access Program management and Real‑World Data collection.

With a global footprint spanning 134 countries, to date we’ve supported over 17,000 patients, 2,900 physicians and 350 sites, earning the trust of 50+ Bio Pharma companies. In October 2025, we closed a €25M investment with Avego Healthcare Capital to fuel our global ambitions and scale the business.

Join us in shaping the future of treatment access - making tomorrow’s therapies accessible for people who need them today.

As a Medical Science Liaison (MSL) at my Tomorrows, you will be part of the Global Access team, serving as a scientific expert and trusted partner to healthcare professionals and Biopharmaceutical clients. You will play a crucial role in supporting access to investigational therapies through Expanded Access Programs, ensuring that medical insights inform our strategy and that patient needs remain at the heart of our mission.

• Build and maintain strong, science‑driven relationships with key opinion leaders (KOLs), physicians, clinical researchers, and patient advocacy groups across assigned regions.
• Provide accurate, balanced, and up‑to‑date scientific and clinical information on investigational treatments via Expanded Access pathways.
• Support EAP operations by engaging with sites, identifying potential investigators, and answering clinical questions from healthcare professionals.
• Deliver scientific education and medical presentations (in‑person and virtual) to healthcare professionals.
• Gather, synthesize, and communicate medical insights and unmet needs to internal stakeholders, helping shape strategy, evidence generation activities, and product improvements.
• Collaborate with Bio Pharma partners to support program onboarding, medical training, protocol education, and ongoing scientific exchange.
• Serve as a subject matter expert internally, advising cross‑functional teams on scientific, clinical, and access related topics.
• Ensure all medical activities adhere to relevant regulatory, ethical, and compliance standards.

• Advanced scientific or clinical degree (Pharm
  
  D, MD, PhD, or equivalent).
• Prior experience in an MSL, medical affairs, clinical development, or research role. Experience with rare diseases, oncology, neurology, or gene therapy is a plus.
• Strong understanding of drug development processes, clinical trials, and Expanded Access.
• Ability to translate complex scientific information into clear, accessible insights tailored to diverse audiences.
• Exceptional relationship‑building skills and a credible, patient‑centric communication style.
• Comfortable engaging with stakeholders across geographies and cultures. Experience in global or multi‑country roles is preferred.
• Self‑starter mentality with the ability to navigate ambiguity in a fast‑growing, mission‑driven environment.
• Willingness to travel domestically (within Germany) and internationally as needed.

• You have built a strong network of engaged physicians, researchers, and key opinion leaders in your assigned region or regions.
• You are recognized internally as a trusted scientific advisor and a reliable partner across Medical Affairs, Operations, and Commercial teams.
• Bio Pharma clients view you as a knowledgeable and credible extension of their program teams.
• You have delivered…